captopril has been researched along with Weight Loss in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bult, H; Herijgers, P; Mubagwa, K; Nevelsteen, I; Van den Bergh, A; Van der Mieren, G; Vanderper, A | 1 |
Beineke, A; Kuttler, B; Lorenz, G; Mullins, JJ; Nicolai, O; Peters, BS; Peters, J; Rettig, R; Thiele, A | 1 |
Capelari, DN; Ciuffo, GM; Fuentes, LB; Ortega, HH; Sánchez, SI | 1 |
de Resende, MM; Greene, AS; Kriegel, AJ | 1 |
Andrés, A; Hernández, E; León, M; Praga, M; Rodicio, JL; Ruilope, LM | 1 |
1 trial(s) available for captopril and Weight Loss
Article | Year |
---|---|
Effects of body-weight loss and captopril treatment on proteinuria associated with obesity.
Topics: Adult; Aged; Blood Pressure; Captopril; Creatinine; Female; Humans; Male; Middle Aged; Obesity; Prospective Studies; Proteinuria; Treatment Outcome; Weight Loss | 1995 |
4 other study(ies) available for captopril and Weight Loss
Article | Year |
---|---|
NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Glucose; Caloric Restriction; Captopril; Combined Modality Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Endothelium, Vascular; Female; Hypertension; Leptin; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Nitric Oxide; Receptors, LDL; Time Factors; Vasodilation; Vasodilator Agents; Weight Loss | 2013 |
The renin-angiotensin system as a primary cause of polyarteritis nodosa in rats.
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antinuclear; Blood Pressure; Body Weight; Captopril; CD3 Complex; Cell Movement; Cytochrome P-450 CYP1A1; Indoles; Male; Polyarteritis Nodosa; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; T-Lymphocytes; Weight Loss | 2010 |
Effects of maternal captopril treatment during late pregnancy on neonatal lung development in rats.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biomarkers; Captopril; Cell Differentiation; Cell Proliferation; Female; Lung; Male; Myofibroblasts; Organ Size; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Weight Loss | 2012 |
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Injections, Subcutaneous; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred Strains; Spironolactone; Ventricular Function, Left; Weight Loss | 2006 |